Table1.
Demographic characteristics.
| All eyes | Treatment-naïve eyes | Pre-treated eyes | p value | |
|---|---|---|---|---|
| Eyes, n | 298 | 175 | 123 | |
| Patients, na | 220b | 136 | 91 | |
| Female, na (%) | 100 (46) | 53 (39) | 48 (53) | |
| Right eye, n (%) | 153 (51) | 91 (52) | 62 (50) | |
| Age years, mean (SD) | 62 (11) | 61 (12) | 63 (9) | 0.10 |
| Diabetes duration years, mean (SD) | 16 (9) | 16 (10) | 15 (7) | 0.70 |
| Diabetes type % | ||||
| Type I | 10 | 12 | 6 | 0.10 |
| Type II | 90 | 88 | 94 | |
| Diabetic retinopathy % | ||||
| Mild | 17 | 20 | 12 | <0.01 |
| Moderate | 39 | 34 | 46 | |
| Severe NPDR | 20 | 17 | 24 | |
| PDR non-high risk | 23 | 28 | 16 | |
| PDR high risk | 1 | 1 | 2 | |
| Baseline VA letters, mean (SD) | 67.7 (14.7) | 67.8 (15.4) | 67.6 (13.8) | 0.94 |
| VA ≥ 69 letters % | 61 | 62 | 59 | 0.70 |
| VA ≤ 35 less % | 5 | 5 | 5 | 1 |
| CST µm, mean (SD) | 402 (109) | 401(110) | 403(108) | 0.92 |
| DMO grades % | ||||
| Centre-involving | 90 | 89 | 92 | |
| Non-centre-involving | 4 | 4 | 4 | 0.48 |
| No DMO | 6 | 7 | 4 | |
n number, SD standard deviation, NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy, VA visual acuity, CST central subfield thickness, DMO diabetic macular oedema.
aPatients with each eye in two groups are repeated.
bData from both eyes of 78 patients were included in the analysis.